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Transcriptional repressorsα, β and γ (RARα, RARβ and RARγ) are nuclear hormone receptors that regulate
fundamental processes during embryogenesis, but their roles in skeletal development and growth remain
unclear. To study skeletal-speciﬁc RAR function, we created conditional mouse mutants deﬁcient in RAR
expression in cartilage. We ﬁnd that mice deﬁcient in RARα and RARγ (or RARβ and RARγ) exhibit severe
growth retardation obvious by about 3 weeks postnatally. Their growth plates are defective and, importantly,
display a major drop in aggrecan expression and content. Mice deﬁcient in RARα and RARβ, however, are
virtually normal, suggesting that RARγ is essential. In good correlation, we ﬁnd that RARγ is the most
strongly expressed RAR in mouse growth plate and its expression characterizes the proliferative and pre-
hypertrophic zones where aggrecan is strongly expressed also. By being avascular, those zones lack
endogenous retinoids as indicated by previous RARE reporter mice and our direct biochemical measurements
and thus, RARγ is likely to exert ligand-less repressor function. Indeed, our data indicate that: aggrecan
production is enhanced by RARγ over-expression in chondrocytes under retinoid-free culture conditions;
production is further boosted by co-repressor Zac1 or pharmacologic agents that enhance RAR repressor
function; and RAR/Zac1 function on aggrecan expression may involve Sox proteins. In sum, our data reveal
that RARs, and RARγ in particular, exert previously unappreciated roles in growth plate function and skeletal
growth and regulate aggrecan expression and content. Since aggrecan is critical for growth plate function, its
deﬁciency in RAR-mutant mice is likely to have contributed directly to their growth retardation.
© 2009 Elsevier Inc. All rights reserved.IntroductionPrenatal and postnatal growth of the skeleton is a complex and
tightly-regulated spatio-temporal process. In most skeletal elements,
growth is attributable to the activity of the growth plates where
chondrocytes proliferate, enlarge into pre-hypertrophic and hyper-
trophic cells, and are ultimately replaced by endochondral bone and
marrow (Wilsman et al., 1996). Growth plate function is directed and
orchestrated by multiple systemic and local factors that include
growth hormone, hedgehog proteins, and Runx and Sox transcrip-
tion factors (Iwamoto et al., 1999; Lefebvre and Smits, 2005; Nilssoned at fax: +1 215 955 9159. M.
. Paciﬁci),
l rights reserved.et al., 2005). In addition, functioning of growth plates depends on
their extracellular matrix composed of aggrecan, collagen II and other
macromolecules (Schwartz and Domowicz, 2002; van der Eerden et al.,
2003). Indeed, abnormalities in matrix gene expression and structure
can cause growth plate malfunction and chondrodysplasias including
dwarﬁsm (ul Haque et al.,1998;Watanabe et al.,1994). For example, the
lethal mouse chondrodystrophy Cartilage Matrix Deﬁciency (cmd) is
caused by stop codon mutations in aggrecan gene; the mutant mice
exhibit short limbs, an enlarged abdomen and cleft palate, and their
growth plates are disorganized (Watanabe et al., 1994). In addition,
aggrecan expression levels and turn-over rates are tightly regulated and
important for normal growth plate function (Shapses et al., 1994;Wang
et al., 2004). Clearly, a normal complement of matrix components is
critical for growth plate function and skeletal growth, but it is far from
clear particularly at the molecular level how matrix homeostasis is
established and maintained.
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nuclear hormone receptors that regulate fundamental processes
during development (Chambon, 1996; Sucov and Evans, 1995). The
RARs form heterodimers with RXRα, RXRβ and RXRγ, interact with
speciﬁc DNA response elements (RAREs) and can act as ligand-
dependent transcriptional activators or ligand-less transcriptional
repressors. When ligands are present, a conformational change
allows interaction with co-activators and proteins with histone
acetyltransferase (HAT) activity (Glass and Rosenfeld, 2000; Moras
and Gronemeyer, 1998). When ligands are absent, the RAR-RXR
dimers bound to RAREs recruit co-repressors, including nuclear
receptor corepressor-1 (NCoR-1) and silencing mediator for retinoic
acid and thyroid hormone receptors (SMRT/NCoR-2) (Chen et al.,
1996; Horlein et al., 2002), and additional factors such as mSin3A
and histone deacetylases (HDACs), thus promoting chromatin
compaction and transcriptional repression. Studies by Chambon
and coworkers ﬁrst established that RARs are differentially
expressed during early steps of limb skeletogenesis and required
for skeletal development (Mendelsohn et al., 1992). While single
RAR-null mice were found to be viable and displayed few defects,
double-null mice lacking RARα/RARγ or RARβ/RARγ died before or
immediately after birth and displayed severe skeletal defects
including homeotic transformations, growth retardation and mal-
formation of limb bones (Lohnes et al., 1994). It has remained largely
unclear ever since, however, what speciﬁc roles the RARs have in
mammalian skeletal development and growth plate functioning. To
address this important issue, we created conditional double mutant
mice deﬁcient in RARα/RARβ, RARα/RARγ or RARβ/RARγ in cartilage.
We ﬁnd that mice deﬁcient in RARα/RARγ or RARβ/RARγ exhibit
signiﬁcant skeletal growth retardation and growth plate abnormal-
ities, whereas mice deﬁcient in RARα/RARβ are essentially normal.
The apparent centrality of RARγ is reafﬁrmed by our extensive in
vitro experiments with wild type and RAR-deﬁcient chondrocytes in
which we have also identiﬁed Zac1 as a likely RAR functional partner.
The data provide novel insights into the molecular regulation of
growth plate function and skeletal growth.
Materials and methods
RAR-deﬁcient mice and genotyping
Floxed RAR mice (RARαf/f, RARβf/f or RARγf/f) (Chapellier et al.,
2002a,b,c) were mated with Col2a1-Cre mice (Ovchinnikov et al.,
2000) to eventually create homozygous double RAR-deﬁcient mice in
cartilage. Brieﬂy, Col2a1-Cre mice were ﬁrst mated with a single RAR
ﬂoxed homozygousmouse to create heterozygous Col2a1-Cre+/RARf/+
mice that were in turn mated to produce Col2a1-Cre+/RARf/f mice
deﬁcient in one RAR in cartilage. To generate double mutant mice,
single RAR deﬁcientmiceweremated to each other to generate double
heterozygous mice (Col2a1-Cre+/RARf/+/RARf/+). Resulting mice,
usually Col2a1-Cre+/RARf/f/RARf/+, were mated to obtain double
RAR-deﬁcient mice (Col2a1-Cre+/RARf/f/RARf/f) in all receptor com-
binations (α/β, α/γ, β/γ). Cre-mediated excision deletes exon 8 in
RARα and RARγ that encodes most of DNA binding domain, and
deletes exons 9 and 10 in RARβ that encodemuch of the ligand-binding
domain. In each case, deletions also cause a frameshift mutation, thus
resulting in functional ablation of all splice forms. Genotyping
procedures and results are shown as Supplementary Figs. S1 and S2.
In situ hybridization, anatomical measurements and RT-PCR
In situ hybridization was carried out with radiolabeled riboprobes
(Iwamoto et al., 2000; Koyama et al., 1999). Plasmids were: pGEM-T
encoding 548–1627 of NM_009024 for RARa; pGEM-T encoding
1480–2116 of XM_127583 for RARb; pGEM-T encoding 1673–2628 of
NM_011244 for RARg that recognize all RARg splice forms. Col9a1,Sox 9, aggrecan and H4C probes were described previously
(Tamamura et al., 2005). Dark and bright ﬁeld images were captured
using a digital camera. In some experiments, dark ﬁeld images were
pseudo-colored using Adobe Photoshop software.
Mice sedated by brief isoﬂuorane exposure were measured from
nose to tail base to nearest 1/10 cm. Femurs were dissected out and
distance from greater trochanter to the medial condyle was measured
with digital calipers to nearest 1/100 mm.
Tibias and vertebrae at L3 level collected from 3- and 5-week-old
double RARβ/RARγ-deﬁcient and double ﬂoxed littermates were ﬁxed
in 4% paraformaldehyde, decalciﬁed in 10% EDTA (pH 7.4) for three
weeks at 4 °C, and embedded in parafﬁn. Control and mutant sections
mounted on same slides were stained with 0.01–0.1%Safranin-O/2%
fast green or 0.1% Alcian blue pH 1.0. Staining was as brief as possible
to avoid dye saturation. Real-time PCR was used to compare levels of
transcriptional co-factors using RNA isolated from newborn tibial and
femoral epiphyseal cartilage. Primer pairs are listed in Table S2 and
genes tested were the following: NCoR1 (nuclear receptor co-
repressor 1) (Jepsen et al., 2000); NCoR2 (also called SMRT)
(Hauksdottir et al., 2002); Lcor (ligand-dependent nuclear receptor
corepressor) (Fernandes et al., 2003); PRAME (preferentially
expressed antigen in melanoma) (Epping et al., 2005); NSD1 (nuclear
receptor binding SET domain protein 1) (Huang et al., 1998); Sorbs3
(sorbin and SH3 domain containing protein 3) (Bour et al., 2005);
Msx1 (msh homeobox 1) (Weston et al., 2003); and Mta1 (metas-
tasis-associated 1) (Mazumdar et al., 2001).
To analyze chondrocyte proliferation, serial sections were
prepared from the proximal tibial growth plates of 3- and 5-week-
old double RARβ/RARγ-deﬁcient and double ﬂoxed littermates.
Sections were hybridized with radiolabeled H4C riboprobes and
then stained with eosin. Bright and dark ﬁeld pictures were taken
from a minimum of 6 slides from each genotype and age then
printed. Each picture was used to manually count every cell present
in the proliferative zone, deﬁned as the tissue area above the Indian
hedgehog-expressing prehypertrophic zone. The same process was
repeated by determining the number of H4C-positive cells; positive
signal was deﬁned as that given by a minimum 5 hybridization
grains per cell. Statistical signiﬁcance was determined by two-tailed
unpaired Student's t-test.
Microcomputed tomography (μCT) analysis
Tibia and femurs were analyzed by μCT at 45 kVp. Trabecular bone
volume, connectivity, trabecular thickness and mineral density were
analyzed and quantiﬁed with a Scanco μCT 40 apparatus using
proprietary software.
Chondrocyte cultures
Cartilage fragments from neonatal epiphyses and 3 to 5-week old
ribs were washed with Ca/Mg-free HBSS plus antibiotics and with
0.05% trypsin/0.01% EDTA. Fragments were incubated in fresh
trypsin/EDTA mixture at 37 °C for 20 min, washed and incubated
with 0.1% testicular collagenase in αMEM for 3–4 h. Neonatal mouse
cartilage tissue was dispersed by pipetting, and single cells were
inoculated onto type I collagen-coated multiwell dishes maintained
in 10% FBS in αMEM. Rib cartilage fragments from 3 and 5 weeks old
mice were partially digested with the initial collagenase treatment.
We found that more than 4 h collagenase treatment not only
damaged cell viability, but also decreased yield of chondrocytes. To
avoid those problems, we maintained partially digested cartilage
fragments for 7–10 days in 10% FBS and 1 ng/ml recombinant basic
FGF (R&D) and then digested again with 0.1% collagenase for 2–3 h.
Ascorbic acid (10 μg/ml) was added to the medium after cells
reached conﬂuency. Cartilage matrix content was determined by
Alcian blue staining (pH 1.0).
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Single reporter assay
4×104 cells per well were seeded onto a type I collagen coated 96
wells plate the day before transfection. Cells weremaintained in 100 μl
10% FBS in MEM. Medium was changed and cells were immediately
transfected with 0.2 μg/well of retinoic acid response element (RARE)
luciferase reporter vector (Panomics, CA) and 0.2 μl of Lipofectamine
LTX (Invitrogen, CA) according to the manufacturer's protocol.
Cultures were treated with indicated doses of all-trans retinoic acid
(RA) (Sigma), RARγ agonist (VTP 204647) or RAR inverse agonist
(INV) (AGN/VTP 194310) for 24 h after transfection; parallel control
cultures received vehicle alone. Forty-eight hours later, cells were
subjected to luciferase assay.
Dual reporter assay
A dual reporter assay system was employed to study the function
of individual RARs and Zac1. Cell seeding and maintenance conditions
were the same as those of the single reporter assay. For gain of
function experiments, 0.1 μg each of expression vector and RARE-lucFig. 1. RAR expression patterns in long bone growth plates. (A–L) In situ hybridization analys
(E–H) and 3 week-old (I–L) proximal tibial growth plates and 3 week-old RARβ/RARγ-deﬁci
arrowhead points to hypertrophic zone. In (L, P), double arrowheads point to primary spon
75 μm.and 1 ng phRG-SV40 (Promega) were co-transfected with 0.2 μl of
Lipofectamine LTX. For loss of function experiments, 0.2 pmol of siRNA
(non-speciﬁc siRNAmixture D-001810-10; SMARTpool siRNAmixture
targeting mouse Zac1(Plagl1), E-046206; RARα, E-047625 and RARγ,
E-040974, Dharmacon, CO), 30 ng RARE-luc and 1 ng phRG-SV40
(Promega) were transfected to each well with 0.2 μl Lipofectamine
2000 reagent (cat. No. 25087w pps, Invitrogen). Some cultures were
treated with various retinoid derivatives from 24 to 48 h after
transfection. Forty-eight hours after transfection, cells were harvested
and subjected to dual luciferase assay (Dual Luciferase Reporter Assay
System, E1910, Promega). Transfection efﬁciency was normalized by
Renilla luciferase activity generated by phRG-SV40.
Protein functional interaction assays
Interactions between RARγ and Zac1 were tested with Promega
Checkmate mammalian two-hybrid system. RARγ and Zac1 subcloned
to pACT and pBIND vectors respectively were transfected to AD293
cells with Lipofectamine LTX reagent. Total 0.2 μg of pACT, pBIND and
pG5-luc (GAL4-luc reporter vector)were transfected at a ratio of 4:4:2.is of RARα, RARβ or RARγ expression using sections of wild type E15.5 (A–D), 1 week-old
ent tibial growth plates (M–P). In (D), arrow points to upper growth plate zones, while
giosa. OC, secondary ossiﬁcation center. Size bars: A–D, 200 μm; E–H, 300 μm; and I–P,
Fig. 2. Physical appearance and skeletal growth in control and RAR-deﬁcient mice. (A)
The two RARβ/RARγ-deﬁcient 5 week-old mice on the right (indicated as βγ-deﬁcient)
are visibly smaller than their control littermates on the left. (B) No obvious difference in
body size is appreciable in 5 week-old control versus RARα/RARβ-deﬁcient littermates.
(C–F) Average body and femur lengths in male and female control and dual RAR-
deﬁcient mice at 8 weeks of age. Body length was measured from nose tip to sacral area.
Numbers of mutant mice analyzed in this experiment are: RARα/RARβ-deﬁcient
(αβ-def, n=13) and control littermate (αβ-cont, n=19), RARβ/RARγ-deﬁcient (βγ-
def, n=24) and its control (βγ-cont, n=32), and RARα/RARγ-deﬁcient (αγ-def,
n=13) and its control littermate (n=14). Control in E and F are total of all three control
littermates (n=65) Obtained data were subjected to the Mann–Whitney test. ⁎pb0.05
compared to βγ-def; #pb0.05 compared to αγ-def.
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Newborn epiphyseal chondrocytes seeded at 2×104 cells/6 mm
well were maintained in 10%FBS/αMEM. When conﬂuent, cultures
were pre-incubated for 24 h in αMEM/0.3%FBS, treated with various
retinoid concentrations for 4 h and labeled with 5 μCi/ml 35S-sulfate
for 20 h. Proteoglycan synthesis was determined by measuring
incorporation of 35S-sulfate into materials precipitated with cetylpyr-
idinium chloride after protease digestion (Takebayashi et al., 1995).
To test RARγ or Zac1 over-expression on proteoglycan synthesis,
chondrocytes were transfected with RARγ (pCMV-HA-RARγ), Zac1
(pCMV-Zac1) or insert-less expression vector using Lipofectamine
LTX reverse transfection protocol in which 0.1 μg of DNA and 0.4 μl
Lipofectamine LTX in 20 μl Opti-MEM medium were dispensed into
each well. Freshly isolated chondrocytes (5×104 cells) suspended in
10% FBS/αMEM medium were seeded onto the pre-coated wells. Six
hours later, mediumwas changed to retinoid-depleted medium (0.5%
charcoal-treated serum, 1× ITS mixture and 0.5% BSA in DMEM) and
cultures were treated with retinoids or left untreated. Cells were lysed
24–48 h after transfection for the reporter gene assay or labeled with
5 μCi/ml of 35S-sulfate for 20 h to measure proteoglycan synthesis.
The parallel cultures that received identical treatmentwere used to
determine DNA contents (Johnson-Wint and Wellis, 1982).
Analysis of endogenous retinoids
This procedure was carried out as described (Kane et al., 2005,
2008). Working in a dark room to protect endogenous retinoids from
light, specimens of upper growth plate zones were isolated from
rabbit rib chondral-osseous junction by microsurgery using a
dissection microscope equipped with yellow ﬁlters. Absolute care
was taken to free the fragments of adjacent perichondrium and other
tissues. Liver fragments were collected from same animals to serve as
internal positive controls. After measuring wet weight of each sample,
tissue fragments were homogenized by several 5–10 s pulses with a
Polytron homogenizer on 1/4 maximum power, and samples were
analyzed and quantiﬁed by LC-MS/MS using an API-4000 (Applied
Biosystems) with atmospheric pressure chemical ionization (APCI) in
positive ion mode.
Results
RAR gene expression patterns
At the outset of this project, we determined the gene expression
patterns of RARα, RARβ and RARγ in mouse limb growth plates,
information that, surprisingly, was still lacking in the literature. In
E15.5 embryos, RARα and RARβ were mildly expressed (Figs. 1A–C),
but RARγwas very strongly expressed in resting, proliferative and pre-
hypertrophic zones (Fig. 1D, arrow) and was down-regulated in
hypertrophic zone (Fig. 1D, arrowhead). Similar overall patterns were
seen in tibial growth plates in 1 week- and 3 week-old mice (Figs. 1E–
H and I–L, respectively), and there was also appreciable RARα
expression in perichondrium (Fig. 1F) and RARγ expression in primary
spongiosa (Fig. 1L, arrowheads). Clearly, the RARs are differentially
expressed in mammalian growth plates and RARγ is the most
abundantly expressed family member.
Conditional compound RAR-deﬁcient mice
To determine RAR roles in growth plate, we produced double RAR-
deﬁcient mice in cartilage by mating ﬂoxed RARmice with Col2a1-Cre
mice (Ovchinnikov et al., 2000) (all with mixed 129/SvPas-C57Bl/6
background). Mutant mice were born at Mendelian ratios. To
determine efﬁciency and speciﬁcity of RAR deletion, DNA samples
from rib and limb growth plate cartilaginous fragments and liver fromnewborn wild type (WT) and double RAR-deﬁcient mice were
processed for genomic PCR, using primers to distinguish wild type
(W), ﬂoxed (F) and null (N) alleles (Fig. S1). RAR genes had been
deleted in mutant cartilage, but not liver (Fig. S1). Efﬁciency of RARγ
ablation in double RARα/RARγ- or RARβ/RARγ-deﬁcient cartilage was
nearly complete (Fig. S1), whereas efﬁciency of RARα and RARβ
ablation averaged over 80% (Fig. S1). Southern hybridization also
showed that RAR genes were deleted in cartilage, but not heart, liver,
brain, spleen and bone marrow DNA; deletion efﬁciency was over 95%
for RARγ and about 80% for RARα and RARβ (Fig. S2). In situ
hybridization on tibial sections from 3 week-old RARβ/RARγ-deﬁcient
mice (Figs.1M–P) conﬁrmed that RARγ gene expressionwasmarkedly
reduced in growth plate (Fig. 1P), but signal was still appreciable over
primary spongiosa (Fig. 1P, arrowhead).
Given that mutant mice were born at Mendelian frequency and
appeared normal at birth, we closely monitored them throughout
maturation. Starting at about 3 weeks, we noted that RARα/RARγ- and
RARβ/RARγ-deﬁcient mice were consistently smaller than control
littermates (heretofore, control littermates represent double ﬂoxed
RAR mice lacking Col2a1-Cre) (Fig. 2A). By 2 months, overall growth
retardation was pronounced in both mutant females and males and
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conﬁrmed in limb skeletal elements such as femurs (Figs. 2E, F). Notably,
mice deﬁcient in RARα/RARβ genes were virtually similar to control
littermates in both body size (Fig. 2B) and skeletal element length (Figs.
2C–F). In total,we examinedover 115mice fromvarious litters (see Fig. 2
legend for details) and the above phenotypic changes in RARα/RARγ-
and RARβ/RARγ-deﬁcient mice were invariably seen. Clearly, deﬁciency
of RARα/RARγ or RARβ/RARγ genes in cartilage causes signiﬁcant
skeletal growth retardation,whereasRARα/RARβ deﬁciency is tolerated.
Growth plate organization and function
What could account for the growth retardation? Normally, growth
plates sustain skeletal growth by: (a) proliferation of chondrocytes;
(b) matrix synthesis and accumulation; and (c) chondrocyte
hypertrophy (Hunziker, 1994; Wilsman et al., 1996). To determine
whether and which of these parameters was affected, longitudinal
serial sections of femoral and tibial growth plates from 3- and 5-week-
old control and RARβ/RARγ-deﬁcient littermates were processed for
histological, histochemical and gene expression analyses. Interest-
ingly, the height of mutant growth plates (Figs. 3B, D, vertical green
line) was consistently shorter than that of control littermates at both
ages (Figs. 3A, C, vertical green line). Shortening appeared to affect
primarily the upper zones (Figs. 3B, D, vertical red line), while the
hypertrophic zone seemed largely unaffected.
To assess proliferation, companion sections were processed for
close histological assessment and for gene expression of histone 4C
(H4C), a general marker of mitotic cells. The average number of
chondrocytes present in the proliferative zone in control 3- and 5-
week-old tibial growth plates was 180±13 and 179±5, respectively.
Interestingly, this number had decreased to 151±15 and 150±11 inFig. 3. Analyses of growth plate organization, chondrocyte proliferation and aggrecan express
I, J) or 5 week-old (C, D, G, H and K, L) control and RARβ/RARγ-deﬁcient littermates were pro
H4C (E–H) or aggrecan (Agg) (I–L). Note the reduction of mutant growth plate height (verti
mice. Size bar, 75 μm.RARβ/RARγ-deﬁcient 3- and 5-week-old tibial growth plates
(pb0.01). A similar trend was observed in companion sections
processed for H4C expression; fewer positive chondrocytes were
present in mutant proliferative zone (Figs. 3F, H, arrowheads) than
control (Figs. 3E, G, arrows).
To monitor matrix synthesis and accumulation, we focused on
aggrecan given its essential role in growth plate function. Aggrecan
transcripts were extremely abundant in control growth plates,
particularly in proliferative and pre-hypertrophic zones (Figs. 3I, K).
In contrast, aggrecan expression was clearly reduced in RARβ/RARγ-
deﬁcient growth plates (Figs. 3J, L). These hybridizations were
conducted with control and mutant growth plate sections mounted
and processed on the same glass slides; thus, hybridization signal is
directly comparable.
To visualize proteoglycans, growth plate sections from 3-week-old
control andmutant littermatesmounted on the same glass slides were
stainedwith Safranin-O or Alcian blue. In controls, staining was strong
(Figs. 4A, C), but was clearly lower in RARβ/RARγ-deﬁcient growth
plates (Figs. 4B, D). Decreases in proteoglycan content were also
observed at other sites in the samemutant animals including vertebral
endplates and annulus ﬁbrosus (Fig. S3).
Given that growth plate function is also required for endochondral
ossiﬁcation (Chan and Jacenko, 1998; Jacenko et al., 1993), we
predicted that the above growth plate defects, and the decrease in
aggrecan content in particular (Poole et al., 1982), should impair
trabecular bone formation. Thus, we subjected tibias and femurs from
control and RAR-deﬁcient littermates to micro-computed tomography
(μCT) to reveal mineralized tissue. Indeed, there was a clear trabecular
bone reduction in RARβ/RARγ-deﬁcient mice (Figs. 4E–H) and RARα/
RARγ-deﬁcient mice (Table S1), while bone structure and quality were
essentially normal in RARα/RARβ-deﬁcient mice (Table S1).ion. (A–L) Serial sections from proximal tibial growth plates of 3 week-old (A, B, E, F and
cessed for histological analysis (A–D) and in situ hybridization for proliferation marker
cal green line) mostly affecting upper zones (red line), and more obvious in 5 week-old
Fig. 4. Histochemical and μCT analyses of long bones. (A–D) Longitudinal sections of
proximal tibial long bone growth plates from 3 and 5 week-old control and RARβ/RARγ-
deﬁcient littermates were processed for histochemical proteoglycan staining with
safranin O or Alcian blue. Note the signiﬁcant reduction in staining in mutant growth
plates. (E–H) Long bones from 5week-old control and RARβ/RARγ-deﬁcient littermates
were scanned by μCT and viewed as 2D pictures (E, F) or 3D cut-plane pictures (G, H).
Note the signiﬁcant decrease in trabecular bone in mutant samples.
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chondrocyte function and bone formation and in particular, promote
aggrecan expression and content.
RARs and proteoglycan expression
If RARs do beneﬁt aggrecan gene expression and production, over-
expression of RARs, and RARγ in particular, should increase such
parameters. It should be noted that endogenous active retinoids are
largely absent in growth plate upper zones (where RARγ and aggrecan
are strongly co-expressed) as indicated by analysis of RARE reporter
mice (von Schroeder and Heersche, 1998) and reiterated by our direct
LC/MS/MS measurements (Fig. S4). Thus, RARγ should inﬂuence
aggrecan expression as ligand-less factor. To test these interesting
possibilities, epiphyseal chondrocytes from newborn wild type mice
were transfected with a CMV-driven expression plasmid encoding
full-length mouse RARγ (HA tagged) or control empty vector. Cells
were maintained in medium containing 0.5% charcoal-stripped
retinoid-free serum (Koyama et al., 1999) and were pulse-labeledwith 35S-sulfate to measure proteoglycan production. Clearly, proteo-
glycan synthesis increased over 30% in RARγ transgene-expressing
cultures compared to controls (Fig. 5A). Chondrocytes isolated from 3-
to 4-week old ribs produced identical data (not shown). To conﬁrm
above data, chondrocytes from RARβ/RARγ-deﬁcient mice were
subjected to same experimentation. Over-expression of RARγ trans-
gene did increase proteoglycan synthesis in these mutant cultures as
well (Fig. 5A). Interestingly, baseline proteoglycan synthesis in
untreated RARβ/RARγ-deﬁcient cultures was consistently lower than
wild-type cultures, likely reﬂecting lower endogenous RAR gene levels
in mutant cells (Fig. 5A).
When RARs are ligand-less, they function as transcriptional
repressors (Koide et al., 2001; Kurosawa et al., 1995; Mannervik et al.,
1999). Based on the data above, one would predict that experimental
increase of RAR repressor function should lead to further increases
in proteoglycan synthesis and levels. To test this intriguing idea, we
resorted to the use of synthetic retinoids that are “inverse agonists”.
Unlike standard agonists (that stimulate RAR transcriptional
activity), inverse agonists stimulate RAR repressor function by
reinforcing co-repressor binding (Germain et al., 2002; Gronemeyer
et al., 2004; Klein et al., 1996; Thacher et al., 1999). Semi-conﬂuent
cultures in charcoal-treated medium were treated with 100 nM
inverse agonist (INV) for 2 days; companion cultures were treated
with vehicle (EtOH). Incorporation of 35S-sulfate did nearly double
in treated versus untreated cultures (Fig. 5B, white histograms).
Companion cultures were treated with 100 or 300 nM of inverse
agonist for 6 days (fresh drug added every two days) to see whether
this prolonged treatment would result in higher proteoglycan
content. Quite clearly, prolonged treatment markedly increased the
amount of Alcian blue-positive proteoglycan matrix compared to
controls (Fig. 5I). This increase was appreciable also by the phase
microscopy appearance of treated chondrocytes that were sur-
rounded by a bright and highly refractive contour (generated by
pericellular proteoglycan accumulation) (Fig. 5E) compared to the
more muted appearance of untreated chondrocytes (Fig. 5C).
If these increases in proteoglycan synthesis and accumulation
reﬂect inverse agonist-dependent stimulation of repressor/co-repres-
sor function, onewould predict that (a) the opposite should be seen in
cultures treated with standard retinoid agonists that induce ligand-
dependent RAR transcriptional activity; and (b) no effects should be
seen in RAR-deﬁcient cultures. In line with these predictions,
treatment of control chondrocyte cultures with all-trans-retinoic
acid (RA) or a RARγ selective agonist: (i) drastically reduced
proteoglycan accumulation (Fig. 5J); (ii) rendered the cells quite
dull in appearance (Fig. 5D); and (iii) markedly decreased proteogly-
can synthesis (not shown). In contrast, no appreciable changes in
these parameters were seen in RARβ/RARγ-deﬁcient cultures that
failed to respond to RA or RARγ selective agonist (Figs. 5G, L) and
inverse agonist (Figs. 5B, K).
Taken together, the above data strengthen the idea that RARs, and
RARγ in particular, are beneﬁcial for proteoglycan expression in
chondrocytes when operating in a retinoid-free condition and thus
possibly as ligand-less repressors.
Searching for RAR co-repressors
Which factors could possibly serve as RAR co-repressors in
cartilage? In other systems the most widely studied co-repressors
are NCoR-1 or NCoR-2/SMRT (Hermanson et al., 2002; Jepsen et al.,
2007), but their possible function in growth plate and skeletal growth
is largely unknown. In addition, studies showed that ligand-less RARα
does recruit NCoR-1 and NCoR-2 efﬁciently, but RARβ and RARγ do
not (Wong and Privalsky, 1998). Given that RARγ is the most
abundantly expressed RAR in growth plate, we searched databases
to identify potential RAR co-repressor candidates using the following
criteria: (1) candidate should associate with nuclear hormone
Fig. 5. Proteoglycan synthesis and content following RARγ over-expression and inverse agonist treatment. (A, B) Proteoglycan synthesis in control and RARβ/RARγ-deﬁcient
chondrocyte cultures over-expressing RARγ (pCMV-HA-RARγ) or following treatment with inverse agonist. (C–H) Phase microscopic appearance of control and RARβ/RARγ-deﬁcient
chondrocytes in untreated control cultures (None) and in companion cultures treated with 300 nM retinoic acid (RA) or 100 nM inverse agonist (INV). (I–L) Alcian blue staining of
control and RARβ/RARγ-deﬁcient cultures treated for 6 days with inverse agonist, RA or a RARγ-selective agonist. Consistency of results was established in three independent
experiments.
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expressed in skeletal tissue. This in silico search led us to Zac1 (zinc
ﬁnger protein which regulates apoptosis and cell cycle arrest)
(Spengler et al., 1997). Zac1 can act as transcriptional co-repressor
or co-activator of nuclear hormone receptors (Huang and Stallcup,
2000) and interestingly, mice lacking Zac1 exhibit growth retardation
and altered bone formation (Varrault et al., 2006).We found that Zac1 is very strongly expressed in mouse growth
plate cartilage; NCoR1 and NCoR-2 are expressed also, but at more
than 5-fold lower levels (Fig. 6A). In situ hybridization on mouse
growth plates conﬁrmed that Zac1 is strongly expressed and,
strikingly, its expression pattern overlaps with that of RARγ, Sox9
and aggrecan (Fig. 6B). Indeed, proteoglycan synthesis in retinoid-free
wild type chondrocyte cultures was stimulated by RARγ over-
Fig. 6. Analyses of Zac1 expression patterns, interactions and function. (A) Real-time PCR analysis of transcriptional co-factors in newborn tibial and femoral epiphyseal cartilage.
Expression levels are shown relative to GAPDH. (B) Expression patterns of Zac1, aggrecan (Agc), RARγ and Sox9 in longitudinal sections of E15.5 mouse embryo tibias viewed at high
(upper panels) and lower magniﬁcation (lower panels). (C) Proteoglycan synthesis in primary chondrocyte cultures following over-expression of Zac1 and/or RARγ. Cultures
maintained in retinoid-free mediumwere pulse-labeled with 35-sulfate from 24 to 36 h after transfection. Graphs show average incorporation in triplicate cultures+/−SD. ⁎pb0.05
by Student's t-test comparing control empty vector transfected cultures vs Zac1 and RARγ transfected cultures. (D) Immunoprecipitation and immunoblot analysis of physical
interaction between RARγ and Zac1 (left panel). Speciﬁcity of Zac1 antibodies was conﬁrmed by immunoprecipitation of whole cell lysates compared to preimmune rabbit IgGs
(right panel). (E) RARE reporter activity in primary cultured chondrocytes following Zac1 over-expression with or without treatment with inverse agonist AGN (left panel). Similar
analyses with or without treatment with retinoic acid (RA) (right panel). (F) Mammalian two hybrid assays showing that RARγ and Zac1 interact to elicit very strong reporter activity
(solid black column). pACT-MyoD and pBIND-Id were used as positive controls, and insert-less pACTand pBINDwere negative controls. (G) RARE reporter activity in primary cultured
chondrocytes following transfection of smart pool siRNA speciﬁc mixtures for Zac1, RARα or RARγwithout (−) or with (+) co-treatment with 100 nM inverse agonist; non-speciﬁc
(NS) was used in controls. (H, I) RT-PCR analysis of endogenous RNA levels for indicated genes following transfection of siRNAs for Zac1 (H) or RARγ (I); note that only the targeted
RNA was decreased in each case. Transfection efﬁciency of all reporter assays was normalized by Renilla luciferase activity generated by co-transfected phRG-SV40 vector. Two
independent siRNA transfection experiments and three independent experiments with all the other transfections were carried out and produced similar results.
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and Zac1 (Fig. 6C). To see that Zac1 actually interacts with RARγ, we
over-expressed RARγ and Zac1 in AD293 cell line and processed
whole cell extracts for Zac1 immunoprecipitation followed bywestern
blot for RARγ; clearly, Zac1 associates with RARγ (Fig. 6D). To test
whether Zac1 inﬂuences RAR function at the RARE level, we co-
transfected wild type chondrocyte cultures with an RARE reporter
construct and a full-length mouse Zac1 expression vector; parallel
cultures received only the RARE reporter construct. Clearly, basal RARE
reporter activity was decreased by Zac1 over-expression and was
further decreased by inverse agonist AGN co-treatment compared tocontrol cells (Fig. 6E). Basal RARE reporter activity, however, was
increased when endogenous Zac1 or RARγ expression was inhibited
by siRNA (Fig. 6G). Inhibition of RARα expression had no effect,
attesting to the importance of RARγ (Fig. 6G); speciﬁcity of siRNAs is
demonstrated in Figs. 6H, I.
Regulation of proteoglycan expression
How could the apparent repressor function of RARs favor aggrecan
gene expression? A reasonable possibility is that ligand-less RARs
stimulate expression of Sox 9 which is a critical regulator of
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expression (Bridgewater et al., 2003; Lefebvre and Smits, 2005). To
assess this possibility, primary semi-conﬂuent chondrocyte cultures
were treated with 100 nM of inverse agonist (INV) for 2 days; for
comparison, companion cultures were treated with a standard
agonist (RA). Whole RNAs were processed for RT-PCR. Inverse
agonist treatment did cause a concurrent stimulation of aggrecan
and Sox9 expression (Figs. 7A, B), while RA inhibited both (Figs. 7A, B).
The same trends were observed in cultures transfected with a Sox
reporter construct that contains 4×48 bp Sox-binding Col2a1Fig. 7. Analyses of aggrecan and Sox9 expression levels and patterns. (A–C) Aggrecan and Sox
cultures treated with 100 nM inverse agonist (INV) or 1 μM RA compared to untreated cult
RARα/RARγ-deﬁcient chondrocyte cultures before (None) or after treatment with inverse ag
obtained reproducible results. (L–O) In situ hybridization analysis of Sox9 expression in 3 we
and RARβ/RARγ-deﬁcient (M and O) littermates.enhancer (Zhou et al., 1998) (Fig. 7C). To verify that these
pharmaceutical agents modulated RAR function at the genomic
level and not via other pathways (Aggarwal et al., 2006; Alsayed
et al., 2001), control and RAR-deﬁcient chondrocyte cultures in
standard medium were transfected with an RARE reporter plasmid
and treated with inverse agonist, RA or RARγ-selective agonist. In
control cultures, the inverse agonist markedly decreased baseline
reporter activity (Fig. 7D) as seen above (see Fig. 6C), while RA or
RARγ-selective agonist markedly stimulated it (Fig. 7H). The same
results were obtained with RARα/RARβ-deﬁcient cultures (Figs. 7E,9 expression levels (A, B) and 4×48 bp Sox reporter activity (C) in primary chondrocyte
ures (None). (D–K) RARE reporter activities in control, RARα/RARβ-, RARβ/RARγ- and
onist, RA or RARγ-selective agonist. All reporter assays were repeated 3–5 times and we
ek-old (L, M) and 5 week-old (N, O) proximal tibial growth plates from control (L and N)
324 J.A. Williams et al. / Developmental Biology 328 (2009) 315–327I). However, no appreciable responses were seen in cultures
deﬁcient in RARβ/RARγ (Figs. 7F, J) or RARα/RARγ (Figs. 7G, K).
If the RARs regulate aggrecan expression via Sox9 as the above data
imply, one would expect to see a decrease in Sox9 expression
accompanying the decrease in aggrecan expression in RARβ/RARγ-
deﬁcient growth plates. In line with this prediction, there was a
consistent and signiﬁcant decrease in Sox9 transcripts in 3 and
5 week-old mutant versus control growth plates (Figs. 7L–O).
Discussion
The study provides fundamentally new insights into RAR roles in
skeletal growth. We ﬁnd that the RARs are differentially expressed in
different zones of prenatal and postnatal mouse long bone growth
plates, with RARγ being the most abundantly expressed member and
its expression prominently characterizing the upper zones. Concur-
rent deﬁciency in RARα/RARγ or RARβ/RARγ in cartilage causes
concurrent defects in growth plates, most notably a reduction in their
overall height and a decrease in chondrocyte proliferation and
aggrecan expression and content. These growth plate defects are
associated with disturbances in primary spongiosa and trabecular
bone that are substandard compared to those seen in control
littermates. Since chondrocyte proliferation and matrix deposition
are amongst the most critical factors in dictating growth rates
(Hunziker, 1994; Wilsman et al., 1996), it is very likely that
deﬁciencies in those two parameters directly led to skeletal growth
retardation in mutant mice. It is clear then that the RARs have
signiﬁcant, but previously unappreciated roles in growth plate
chondrocyte function and exert local inﬂuence on skeletal growth.
The data correlate quite well and greatly extend previous ﬁndings
obtained with general dual RARα/RARγ- or RARβ/RARγ-null mice
(Mendelsohn et al., 1994). The additional skeletal deformities seen in
those mice and their neonatal lethality likely reﬂect broader systemic
deﬁciencies due to general dual RAR deletion. On the other hand, the
relatively mild defects in single RAR-null mutants reiterate the idea
that other family members can compensate for lack of one RAR gene.
Postnatal growth retardation
Our data show that the skeletal growth retardation affecting
RARα/RARγ- and RARβ/RARγ-deﬁcient mice became apparent around
3 weeks of age, continued into adulthood and was not compensated
for throughout maturation. The apparent lack of growth retardation at
a younger age correlates well with our observation that the mutant
micewere born at expectedMendelian frequencies andmay thus have
been largely refractory to RAR deﬁciency during prenatal develop-
mental stages. It has long been appreciated that prenatal skeletal
growth is largely controlled by local autocrine and paracrine factors
including Indian hedgehog, whereas systemic factors become impor-
tant postnatally (Fowden, 1995; Kronenberg, 2003; Nilsson et al.,
2005). For example, growth hormone has no apparent role in mouse
embryonic skeletal growth despite the fact that its receptor is
expressed, but GH-deﬁciency causes postnatal growth retardation
starting around 2 weeks of age. Related studies showed that
concurrent deﬁciency in GH and insulin-like growth factor 1 (or
liver IGF-1 and acid labile subunit) cause severe mouse skeletal
growth retardation starting around 3 weeks postnatally (Lupu et al.,
2001; Yakar et al., 2002). A similar trend was observed in transgenic
mice expressing the Achondroplasia mutant form of human FGF-R3;
themicewere apparently normal during prenatal and neonatal stages,
but became growth retarded starting around 4 weeks of age, with a
concurrent decrease in growth plate chondrocyte proliferation (Naski
et al., 1998). Clearly, skeletal growth is a complex process that obeys a
multitude of common and distinct pathways and mechanisms during
prenatal and postnatal life. Our data show that RAR deﬁciency is well
tolerated during prenatal and neonatal growth, but cannot becompensated and becomes deleterious to growth starting around
3 weeks of age by a combination of decreases in aggrecan production
and deposition and chondrocyte proliferation. Whether the RAR
deﬁciency affected the chondrocytes' ability to respond to, and be
inﬂuenced by, systemic factors remains to be established.
Retinoids and repressor function
Cartilage is unique among tissues for its avascular nature and
growth plate cartilage is no exception, particularly in its upper zones.
In fact, the growth plate is largely hypoxic and is quite sensitive to
ablation of genes needed to cope with such an unusual metabolic
status (Schipani et al., 2001). Given the absence of blood vessels, it is
likely that the upper growth plate zones cannot receive liver-derived,
blood-bourn and protein-bound retinoid precursors needed for
intracellular production of biologically-active retinoids (Blaner and
Olson, 1994) and would thus be largely devoid of such retinoids.
Indeed, von Schroeder and Heersche showed with a widely-used
RARE reporter mouse line (Rossant et al., 1991) that the upper zones
of mouse limb growth plates are virtually devoid of reporter activity
and hence active retinoids, while reporter activity is detectable in the
lower hypertrophic zone and other retinoid-rich organs (von
Schroeder and Heersche, 1998). Our direct measurements of
endogenous retinoic acid in upper growth plate zones by ultra-
sensitive LC/MS/MS procedures (Kane et al., 2005, 2008) verify
those observations (Fig. S4). Together, these studies suggest that
RARs expressed in upper growth plate zones are largely devoid of
active ligands and could primarily, if not exclusively, exert ligand-less
repressor function. Growth plate defects seen in our RARα/RARγ- or
RARβ/RARγ-deﬁcient mice would thus result from absence of such
repressor function.
Nuclear receptor-mediated transcriptional repression is as impor-
tant as transcriptional activation in regulating developmental
processes (Kurosawa et al., 1995; Mannervik et al., 1999). For
example, NCoR- or HDAC1-null mice die during gestation (Jepsen
et al., 2000; Lagger et al., 2002), and ablation of HDAC4 (normally
expressed by pre-hypertrophic chondrocytes) deranges growth plate
chondrocyte maturation and causes premature hypertrophy (Vega
et al., 2004). It is conceivable then that ligand-less RARs expressed
in upper growth plate zones, and RARγ in particular, could cooperate
with HDACs such as HDAC4 to repress target genes, maintain
chondrocyte function in those zones including aggrecan expression,
and allow growth plate and skeletal growth to proceed at normal
rates. Interestingly, our data indicate that Sox9 gene expression is
lower in RARβ/RARγ-deﬁcient growth plates and is stimulated by
inverse agonist treatment in cultured chondrocytes (along with a
stimulation in proteoglycan synthesis). A recent relevant report is
showing that ligand-bound RARs or TNFα suppress cartilage-matrix
gene expression by limiting availability of p300, an essential co-
factor for Sox9 activity (Rockel et al., 2008). The ﬁndings suggest that
p300 available for activation of Sox9 increases when RARs are ligand-
less. Thus, a normal in vivo role of RAR repressor function in growth
plate could be to favor Sox 9 expression and function together with
p300 and promote the chondrocyte phenotype. A similar RAR
repressor function, largely mediated by RARα, operates during limb
mesenchymal chondrogenic cell differentiation and is required for
initial up-regulation of Sox 9 gene expression (Weston et al., 2002).
These authors suggested that RARα-dependent repressor function
would directly block expression of “gene X”, a negative regulator of
Sox9 gene expression. Though the nature of gene X in chondrogenesis
remains unknown, progress has been made in other systems. For
instance, Jepsen et al. reported recently that NCoR-2/SMRT and
ligand-less RARs cooperate to directly repress expression of histone
demethylase JMJD3 and in so doing, allow normal spatio-temporal
progression of differentiation of neural stem cells into neurons
(Jepsen et al., 2007).
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While the nature of putative direct targets of RAR repression in
growth plate cartilage also awaits further work, our current data have
identiﬁed Zac1 as a possible RAR co-factor. Our data not only show
that the Zac1 expression pattern is remarkably similar to that of RARγ
in growth plate, but also that: Zac1 functionally associates with RARγ;
Zac1 over-expression further boosts proteoglycan production in
retinoid-free chondrocyte cultures; and Zac1 and RARγ co-operate
to reduce transcription rates as revealed by RARE reporter assays. As
noted above, Zac1 is an essential factor for many developmental
processes (Spengler et al., 1997), and Zac1-null mice die at birth and
exhibit signiﬁcant defects including growth retardation and altered
bone formation (Varrault et al., 2006). These authors performed a
detailed in silico network gene analysis, carried out direct promoter
and gene expression tests, and concluded that Zac1 is upstream of a
number of systemic genes, including Igf2/H19, Cdkn1c and Dlk1, that
would together control embryonic growth. Since the growth plates of
the Zac1-null mice were not studied, the authors did not clarify what
consequences the general ablation of Zac1 had for local chondrocyte
and/or osteoblast function. Based on our data, we may surmise that
absence of Zac1 could have diminished RAR repressor function in the
growth plate, should have affected the same phenotypic traits
deranged by conditional RAR ablation such as aggrecan expression,
and may even have had additional systemically-driven consequences
due to substandard expression of upstream genes.
Our two hybrid tests suggest that Zac1 and RARγ exhibit functional
interaction, and this may possibly reﬂect physical interaction. Similar
to the RARs (Chambon, 1996), Zac1 is distinguished into several
functional domains: an N-terminal zinc ﬁnger region; a central
proline-rich region; a small and highly-conserved motif rich in
hydrophobic amino acids (termed ΦXXΦΦ motif or NR box); and a
C-terminal P/E-rich domain (Spengler et al., 1997). Using pull-down
assays, Huang et al. showed that Zac1 interacts with the AF2 domain of
androgen, estrogen and thyroid hormone receptors (Huang and
Stallcup, 2000), and it is possible that Zac1 could interact with the
same domain in RARs. Interestingly, our in silico analysis has not yet
identiﬁed a consensus sequence in Zac1 for interaction with HDACs
(unpublished data). Thus, possible Zac1/RAR complexes may recruit
HDACs indirectly by association with other HDAC-binding factors or
may use alternative strategies, including SUMOylation as shown for
NCoR1 (Tiefenbach et al., 2006).
Derangement of growth plate function
The concurrent decreases in aggrecan expression, chondrocyte
proliferation and trabecular bone deposition point to multiple
important contributions of RARs in proper growth plate functioning.
As our in vivo and in vitro data suggest, it is plausible that decreased
RAR function may have led to decreased Sox 9 gene expression which
would in turn cause decreased aggrecan expression and substandard
matrix deposition. A very interesting and far-reaching implication of
these ﬁndings and conclusions is that experimental stimulation of
RAR repressor function in cartilage by genetic means or pharmaco-
logical agents (such as the one used in our study) could actually have
therapeutic value and could be used to stabilize or improve the
phenotype and matrix production of chondrocytes including articular
chondrocytes.
What could account for the other growth plate changes in RAR-
deﬁcient mice? Chondrocyte proliferation is obviously essential for
skeletal development and growth and counterbalances the loss of
hypertrophic chondrocytes occurring at the chondro-osseous border.
Chondrocyte proliferation is controlled by systemic factors (Nilsson et
al., 2005) and local mechanisms such as those regulated by Indian
hedgehog (Ihh) (Shimo et al., 2004; St-Jacques et al., 1999).
Interestingly, treatment of growth plate chondrocyte cultures withretinoic acid (that induces RAR transcriptional activity) was found to
strongly suppress Ihh expression (Wu et al., 2002). Thus, it is possible
that under normal circumstances ligand-less RAR repressor function
in upper growth plate zones may help to maintain physiologic Ihh
expression levels.
Similarly, it remains to be clariﬁed what caused the presence of
substandard trabecular bone in the RARα/RARγ- or RARβ/RARγ-
deﬁcient mice. As pointed out above, it has long been appreciated that
normal growth plate function and normal matrix composition are
required for trabecular bone deposition. A ﬁrst clue into such
previously unsuspected paradigm came from the work of Poole and
coworkers who originally showed that aggrecan persists in the
calciﬁed cartilage core of primary spongiosa trabeculae and is later
removed by proteolytic action once the secondary spongiosa is laid
down (Poole et al., 1982). A ﬁrst genetic clue was provided by Jacenko
and coworkers who showed that mice with altered growth plate
collagen X function develop a skeleto-hematopoietic disease pheno-
type that includes a compressed growth plate, reduced primary
spongiosa, and marrow hypoplasia (Gress and Jacenko, 2000). In an
intriguing twist, it was realized recently that general deletion of RARγ,
but not RARα, in mice actually causes bone marrow defects
characterized by hematopoietic stem cell alterations and even a
marked reduction in trabecular bone during aging (Purton et al., 2006;
Walkley et al., 2007). It is pretty clear then that there are essential and
intimate cross-talk interactions between growth plates and bone
marrow required for physiologic progression of skeletal growth and
development of hematopoietic and osteoprogenitor cells that can be
deranged by malfunctioning of either growth plate or bone marrow.
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